1.The Pattern of Care for Brain Metastasis from Breast Cancer over the Past 10 Years in Korea: A Multicenter Retrospective Study (KROG 16-12)
Jae Sik KIM ; Kyubo KIM ; Wonguen JUNG ; Kyung Hwan SHIN ; Seock-Ah IM ; Hee-Jun KIM ; Yong Bae KIM ; Jee Suk CHANG ; Jee Hyun KIM ; Doo Ho CHOI ; Yeon Hee PARK ; Dae Yong KIM ; Tae Hyun KIM ; Byung Ock CHOI ; Sea-Won LEE ; Suzy KIM ; Jeanny KWON ; Ki Mun KANG ; Woong-Ki CHUNG ; Kyung Su KIM ; Ji Ho NAM ; Won Sup YOON ; Jin Hee KIM ; Jihye CHA ; Yoon Kyeong OH ; In Ah KIM
Cancer Research and Treatment 2022;54(4):1121-1129
Purpose:
We aimed to investigate manifestations and patterns of care for patients with brain metastasis (BM) from breast cancer (BC) and compared their overall survival (OS) from 2005 through 2014 in Korea.
Materials and Methods:
We retrospectively reviewed 600 BC patients with BM diagnosed between 2005 and 2014. The median follow-up duration was 12.5 months. We categorized the patients into three groups according to the year when BM was initially diagnosed (group I [2005-2008], 98 patients; group II [2009-2011], 200 patients; and group III [2012-2014], 302 patients).
Results:
Over time, the median age at BM diagnosis increased by 2.2 years (group I, 49.0 years; group II, 48.3 years; and group III, 51.2 years; p=0.008). The percentage of patients with extracranial metastasis was 73.5%, 83.5%, and 86.4% for group I, II, and III, respectively (p=0.011). The time interval between BC and BM was prolonged in patients with stage III primary BC (median, 2.4 to 3 years; p=0.029). As an initial brain-directed treatment, whole-brain radiotherapy alone decreased from 80.0% in 2005 to 41.1% in 2014. Meanwhile, stereotactic radiosurgery or fractionated stereotactic radiotherapy alone increased from 13.3% to 34.7% during the same period (p=0.005). The median OS for group I, II, and III was 15.6, 17.9, and 15.0 months, respectively, with no statistical significance.
Conclusion
The manifestations of BM from BC and the pattern of care have changed from 2005 to 2014 in Korea. However, the OS has remained relatively unchanged over the 10 years.
2.Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia
Young Hoon PARK ; Dae-Young KIM ; Yeung-Chul MUN ; Eun Kyung CHO ; Jae Hoon LEE ; Deog-Yeon JO ; Inho KIM ; Sung-Soo YOON ; Seon Yang PARK ; Byoungkook KIM ; Soo-Mee BANG ; Hawk KIM ; Young Joo MIN ; Jae Hoo PARK ; Jong Jin SEO ; Hyung Nam MOON ; Moon Hee LEE ; Chul Soo KIM ; Won Sik LEE ; So Young CHONG ; Doyeun OH ; Dae Young ZANG ; Kyung Hee LEE ; Myung Soo HYUN ; Heung Sik KIM ; Sung-Hyun KIM ; Hyukchan KWON ; Hyo Jin KIM ; Kyung Tae PARK ; Sung Hwa BAE ; Hun Mo RYOO ; Jung Hye CHOI ; Myung-Ju AHN ; Hwi-Joong YOON ; Sung-Hyun NAM ; Bong-Seog KIM ; Chu-Myong SEONG
The Korean Journal of Internal Medicine 2022;37(4):841-850
Background/Aims:
We evaluated the feasibility and long-term efficacy of the combination of cytarabine, idarubicin, and all-trans retinoic acid (ATRA) for treating patients with newly diagnosed acute promyelocytic leukemia (APL).
Methods:
We included 87 patients with newly diagnosed acute myeloid leukemia and a t(15;17) or promyelocytic leukemia/retinoic acid receptor alpha (PML-RARα) mutation. Patients received 12 mg/m2/day idarubicin intravenously for 3 days and 100 mg/m2/day cytarabine for 7 days, plus 45 mg/m2/day ATRA. Clinical outcomes included complete remission (CR), relapse-free survival (RFS), overall survival (OS), and the secondary malignancy incidence during a 20-year follow-up.
Results:
The CR, 10-year RFS, and 10-year OS rates were 89.7%, 94.1%, and 73.8%, respectively, for all patients. The 10-year OS rate was 100% for patients that achieved CR. Subjects were classified according to the white blood cell (WBC) count in peripheral blood at diagnosis (low-risk, WBC < 10,000/mm3; high-risk, WBC ≥ 10,000/mm3). The low-risk group had significantly higher RFS and OS rates than the high-risk group, but the outcomes were not superior to the current standard treatment (arsenic trioxide plus ATRA). Toxicities were similar to those observed with anthracycline plus ATRA, and higher than those observed with arsenic trioxide plus ATRA. The secondary malignancy incidence after APL treatment was 2.7%, among the 75 patients that achieved CR, and 5.0% among the 40 patients that survived more than 5 years after the APL diagnosis.
Conclusions
Adding cytarabine to anthracycline plus ATRA was not inferior to anthracycline plus ATRA alone, but it was not comparable to arsenic trioxide plus ATRA. The probability of secondary malignancy was low.
3.Effect of epidural corticosteroid injection on magnetic resonance imaging findings.
Min Soo KIM ; Tae Yoon JEONG ; Yu Seon CHEONG ; Young Wook JEON ; So Young LIM ; Seong Sik KANG ; In Nam KIM ; Tsong Bin CHANG ; Hyun Ho SEONG ; Byeong Mun HWANG
The Korean Journal of Pain 2017;30(4):281-286
BACKGROUND: Magnetic resonance imaging (MRI) of the spine is the preferred diagnostic tool for pathologic conditions affecting the spine. However, in patients receiving epidural corticosteroid injection (ESI) for treatment of spinal diseases, there is a possibility of misreading of MR images because of air or fluid in the epidural space after the injection. Therefore, we defined the characteristics of abnormal changes in MRI findings following an ESI in patients with low back pain. METHODS: We reviewed the medical records of 133 patients who underwent MRI of the lumbar spine within 7 days after ESI between 2006 and 2015.All patients were administered an ESI using a 22-gauge Tuohy needle at the lumbar spine through the interlaminar approach. The epidural space was identified by the loss of resistance technique with air. RESULTS: The incidences of abnormal changes in MRI findings because of ESI were 54%, 31%, and 25% in patients who underwent MRI at approximately 24 h, and 2 and 3 days after ESI, respectively. Abnormal MRI findings included epidural air or fluid, needle tracks, and soft tissue changes. Epidural air, the most frequent abnormal finding (82%), was observed in 41% of patients who underwent MRI within 3 days after injection. Abnormal findings due to an ESI were not observed in MR images acquired 4 days after ESI or later. CONCLUSIONS: Pain physicians should consider the possibility of abnormal findings in MR images acquired after epidural injection using the interlaminar approach and the loss of resistance technique with air at the lumbar spine.
Artifacts
;
Epidural Space
;
Glucocorticoids
;
Humans
;
Incidence
;
Injections, Epidural
;
Low Back Pain
;
Magnetic Resonance Imaging*
;
Medical Records
;
Needles
;
Spinal Diseases
;
Spine
4.Comparison of Multi-Echo Dixon Methods with Volume Interpolated Breath-Hold Gradient Echo Magnetic Resonance Imaging in Fat-Signal Fraction Quantification of Paravertebral Muscle.
Yeon Hwa YOO ; Hak Sun KIM ; Young Han LEE ; Choon Sik YOON ; Mun Young PAEK ; Hanna YOO ; Stephan KANNENGIESSER ; Tae Sub CHUNG ; Ho Taek SONG ; Jin Suck SUH ; Sungjun KIM
Korean Journal of Radiology 2015;16(5):1086-1095
OBJECTIVE: To assess whether multi-echo Dixon magnetic resonance (MR) imaging with simultaneous T2* estimation and correction yields more accurate fat-signal fraction (FF) measurement of the lumbar paravertebral muscles, in comparison with non-T2*-corrected two-echo Dixon or T2*-corrected three-echo Dixon, using the FF measurements from single-voxel MR spectroscopy as the reference standard. MATERIALS AND METHODS: Sixty patients with low back pain underwent MR imaging with a 1.5T scanner. FF mapping images automatically obtained using T2*-corrected Dixon technique with two (non-T2*-corrected), three, and six echoes, were compared with images from single-voxel MR spectroscopy at the paravertebral muscles on levels L4 through L5. FFs were measured directly by two radiologists, who independently drew the region of interest on the mapping images from the three sequences. RESULTS: A total of 117 spectroscopic measurements were performed either bilaterally (57 of 60 subjects) or unilaterally (3 of 60 subjects). The mean spectroscopic FF was 14.3 +/- 11.7% (range, 1.9-63.7%). Interobserver agreement was excellent between the two radiologists. Lin's concordance correlation between the spectroscopic findings and all the imaging-based FFs were statistically significant (p < 0.001). FFs obtained from the T2*-corrected six-echo Dixon sequences showed a significantly better concordance with the spectroscopic data, with its concordance correlation coefficient being 0.99 and 0.98 (p < 0.001), as compared with two- or three-echo methods. CONCLUSION: T2*-corrected six-echo Dixon sequence would be a better option than two- or three-echo methods for noninvasive quantification of lumbar muscle fat quantification.
Adult
;
Aged
;
Aged, 80 and over
;
Female
;
Humans
;
Image Processing, Computer-Assisted
;
Low Back Pain/*radiography
;
Magnetic Resonance Imaging/instrumentation/*methods
;
Male
;
Middle Aged
;
Muscles/radiography
;
Spinal Cord
5.Differentiation between Focal Malignant Marrow-Replacing Lesions and Benign Red Marrow Deposition of the Spine with T2*-Corrected Fat-Signal Fraction Map Using a Three-Echo Volume Interpolated Breath-Hold Gradient Echo Dixon Sequence.
Yong Pyo KIM ; Stephan KANNENGIESSER ; Mun Young PAEK ; Sungjun KIM ; Tae Sub CHUNG ; Yeon Hwa YOO ; Choon Sik YOON ; Ho Taek SONG ; Young Han LEE ; Jin Suck SUH
Korean Journal of Radiology 2014;15(6):781-791
OBJECTIVE: To assess the feasibility of T2*-corrected fat-signal fraction (FF) map by using the three-echo volume interpolated breath-hold gradient echo (VIBE) Dixon sequence to differentiate between malignant marrow-replacing lesions and benign red marrow deposition of vertebrae. MATERIALS AND METHODS: We assessed 32 lesions from 32 patients who underwent magnetic resonance imaging after being referred for assessment of a known or possible vertebral marrow abnormality. The lesions were divided into 21 malignant marrow-replacing lesions and 11 benign red marrow depositions. Three sequences for the parameter measurements were obtained by using a 1.5-T MR imaging scanner as follows: three-echo VIBE Dixon sequence for FF; conventional T1-weighted imaging for the lesion-disc ratio (LDR); pre- and post-gadolinium enhanced fat-suppressed T1-weighted images for the contrast-enhancement ratio (CER). A region of interest was drawn for each lesion for parameter measurements. The areas under the curve (AUC) of the parameters and their sensitivities and specificities at the most ideal cutoff values from receiver operating characteristic curve analysis were obtained. AUC, sensitivity, and specificity were respectively compared between FF and CER. RESULTS: The AUCs of FF, LDR, and CER were 0.96, 0.80, and 0.72, respectively. In the comparison of diagnostic performance between the FF and CER, the FF showed a significantly larger AUC as compared to the CER (p = 0.030), although the difference of sensitivity (p = 0.157) and specificity (p = 0.157) were not significant. CONCLUSION: Fat-signal fraction measurement using T2*-corrected three-echo VIBE Dixon sequence is feasible and has a more accurate diagnostic performance, than the CER, in distinguishing benign red marrow deposition from malignant bone marrow-replacing lesions.
Adult
;
Aged
;
Aged, 80 and over
;
Area Under Curve
;
Bone Marrow Cells/cytology
;
Bone Marrow Transplantation
;
Contrast Media/diagnostic use
;
Diagnosis, Differential
;
Female
;
Humans
;
*Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
ROC Curve
;
Sensitivity and Specificity
;
Signal-To-Noise Ratio
;
Spinal Diseases/diagnosis/*radiography
6.Determination of Malignant and Invasive Predictors in Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Suggested Scoring Formula.
Dae Wook HWANG ; Jin Young JANG ; Chang Sup LIM ; Seung Eun LEE ; Yoo Seok YOON ; Young Joon AHN ; Ho Seong HAN ; Sun Whe KIM ; Sang Geol KIM ; Young Kook YUN ; Seong Sik HAN ; Sang Jae PARK ; Tae Jin LIM ; Koo Jung KANG ; Mun Sup SIM ; Seong Ho CHOI ; Jin Seok HEO ; Dong Wook CHOI ; Kyung Yul HUR ; Dong Shik LEE ; Sung Su YUN ; Hong Jin KIM ; Chul Kyoon CHO ; Hyun Jong KIM ; Hee Chul YU ; Baik Hwan CHO ; In Sang SONG
Journal of Korean Medical Science 2011;26(6):740-746
Prediction of malignancy or invasiveness of branch duct type intraductal papillary mucinous neoplasm (Br-IPMN) is difficult, and proper treatment strategy has not been well established. The authors investigated the characteristics of Br-IPMN and explored its malignancy or invasiveness predicting factors to suggest a scoring formula for predicting pathologic results. From 1994 to 2008, 237 patients who were diagnosed as Br-IPMN at 11 tertiary referral centers in Korea were retrospectively reviewed. The patients' mean age was 63.1 +/- 9.2 yr. One hundred ninty-eight (83.5%) patients had nonmalignant IPMN (81 adenoma, 117 borderline atypia), and 39 (16.5%) had malignant IPMN (13 carcinoma in situ, 26 invasive carcinoma). Cyst size and mural nodule were malignancy determining factors by multivariate analysis. Elevated CEA, cyst size and mural nodule were factors determining invasiveness by multivariate analysis. Using the regression coefficient for significant predictors on multivariate analysis, we constructed a malignancy-predicting scoring formula: 22.4 (mural nodule [0 or 1]) + 0.5 (cyst size [mm]). In invasive IPMN, the formula was expressed as invasiveness-predicting score = 36.6 (mural nodule [0 or 1]) + 32.2 (elevated serum CEA [0 or 1]) + 0.6 (cyst size [mm]). Here we present a scoring formula for prediction of malignancy or invasiveness of Br-IPMN which can be used to determine a proper treatment strategy.
Adenocarcinoma, Mucinous/*pathology
;
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoembryonic Antigen/blood
;
Carcinoma, Pancreatic Ductal/*pathology
;
Carcinoma, Papillary/*pathology
;
Female
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Neoplasm Invasiveness
;
Neoplasm Staging
;
Pancreatic Neoplasms/*pathology
;
Predictive Value of Tests
;
ROC Curve
;
Tomography, X-Ray Computed
7.Preliminary Report of the 1998~1999 Patterns of Care Study of Radiation Therapy for Esophageal Cancer in Korea.
Won Joo HUR ; Youngmin CHOI ; Hyung Sik LEE ; Jeung Kee KIM ; Il Han KIM ; Ho Jun LEE ; Kyu Chan LEE ; Jung Soo KIM ; Mi Son CHUN ; Jin Hee KIM ; Yong Chan AHN ; Sang Gi KIM ; Bo Kyung KIM ; Taek Keun NAM ; Doo Ho CHOI ; Ki Mun KANG ; Byung Hyun KWON ; Dae Yong KIM ; Ji Young JANG ; Seung Chang SOHN ; Hyun Suk SUH ; Dae Sik YANG ; Woo Chul KIM ; Chang Ok SUH ; Kijung AHN ; Tae Sik JEUNG
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2007;25(2):79-92
PURPOSE: For the first time, a nationwide survey in the Republic of Korea was conducted to determine the basic parameters for the treatment of esophageal cancer and to offer a solid cooperative system for the Korean Pattern of Care Study database. MATERIALS AND METHODS: During 1998~1999, biopsy-confirmed 246 esophageal cancer patients that received radiotherapy were enrolled from 23 different institutions in South Korea. Random sampling was based on power allocation method. Patient parameters and specific information regarding tumor characteristics and treatment methods were collected and registered through the web based PCS system. The data was analyzed by the use of the Chi-squared test. RESULTS: The median age of the collected patients was 62 years. The male to female ratio was about 91 to 9 with an absolute male predominance. The performance status ranged from ECOG 0 to 1 in 82.5% of the patients. Diagnostic procedures included an esophagogram (228 patients, 92.7%), endoscopy (226 patients, 91.9%), and a chest CT scan (238 patients, 96.7%). Squamous cell carcinoma was diagnosed in 96.3% of the patients; mid-thoracic esophageal cancer was most prevalent (110 patients, 44.7%) and 135 patients presented with clinical stage III disease. Fifty seven patients received radiotherapy alone and 37 patients received surgery with adjuvant postoperative radiotherapy. Half of the patients (123 patients) received chemotherapy together with RT and 70 patients (56.9%) received it as concurrent chemoradiotherapy. The most frequently used chemotherapeutic agent was a combination of cisplatin and 5-FU. Most patients received radiotherapy either with 6 MV (116 patients, 47.2%) or with 10 MV photons (87 patients, 35.4%). Radiotherapy was delivered through a conventional AP-PA field for 206 patients (83.7%) without using a CT plan and the median delivered dose was 3,600 cGy. The median total dose of postoperative radiotherapy was 5,040 cGy while for the non-operative patients the median total dose was 5,970 cGy. Thirty-four patients received intraluminal brachytherapy with high dose rate Iridium-192. Brachytherapy was delivered with a median dose of 300 cGy in each fraction and was typically delivered 3~4 times. The most frequently encountered complication during the radiotherapy treatment was esophagitis in 155 patients (63.0%). CONCLUSION: For the evaluation and treatment of esophageal cancer patients at radiation facilities in Korea, this study will provide guidelines and benchmark data for the solid cooperative systems of the Korean PCS. Although some differences were noted between institutions, there was no major difference in the treatment modalities and RT techniques.
Brachytherapy
;
Carcinoma, Squamous Cell
;
Chemoradiotherapy
;
Cisplatin
;
Drug Therapy
;
Endoscopy
;
Esophageal Neoplasms*
;
Esophagitis
;
Female
;
Fluorouracil
;
Humans
;
Korea*
;
Male
;
Photons
;
Radiotherapy
;
Republic of Korea
;
Tomography, X-Ray Computed
8.A Case of Term Delivery in Heterotopic Pregnancy following a Natural Conception.
So Hee KIM ; Myeong Su JUNG ; Ju Sup JUNG ; Tae Sik MUN ; Sang Eon LEE
Korean Journal of Obstetrics and Gynecology 2006;49(5):1158-1164
Heterotopic pregnancy, simultaneous intrauterine and extrauterine gestations, is a relatively rare conditon with an estimated incidence of 1 in 30,000 pregnancies in a natural cycle. But the incidence of heterotopic pregnancies has been increased because of rising incidence of pelvic inflammatory disease, pelvic surgery, intrauterine device, the use of various ovulation induction and assisted reproductive technologies, such as in vitro fertilization and embryo transfer, gamate intrafallopian insemination. The early diagnosis of heterotopic pregnancy is very difficult. So there is a higher maternal morbidity, mortality and fetal loss. Thus careful pelvic examination, combined with serial beta hCG determinations and transvaginal sonography to evaluate the adnexal region are important. We experienced a case of 34-years-old multiparous women with heterotopic pregnancy in natual cycle confirmed by surgical removal of ruptured right tubal pregnancy and sonographic finding of the intrauterine pregnancy, which carried the intrauterine pregnancy to term delivery without complication at 39+5 weeks of gestation, and report this case with a brief review of the literature.
Early Diagnosis
;
Embryo Transfer
;
Female
;
Fertilization in Vitro
;
Fertilization*
;
Gynecological Examination
;
Humans
;
Incidence
;
Insemination
;
Intrauterine Devices
;
Mortality
;
Ovulation Induction
;
Pelvic Inflammatory Disease
;
Pregnancy
;
Pregnancy, Heterotopic*
;
Pregnancy, Tubal
;
Reproductive Techniques, Assisted
;
Ultrasonography
9.Docetaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer.
Seok Bong JEON ; Byung Min AHN ; Jun Ho MUN ; Woo Jin SUNG ; Dong Hwan KIM ; Jong Gwang KIM ; Tae Bong KIM ; Ho Young JUNG ; Wan Sik YU ; Sang Kyun SOHN ; Kyu Bo LEE
Korean Journal of Medicine 2005;68(6):672-677
BACKGROUND: We evaluated the efficacy and toxicity of docetaxel plus cisplatin combination as first-line chemotherapy for advanced gastric cancer. METHODS: Patients with metastatic or recurrent gastric adenocarcinoma, performance score
10.Therapeutic Compliance with Hypertension in Rural Elderly.
Tae Min KIM ; Moo Sik LEE ; Baeg Ju NA ; Keon Yup KIM ; Jee Young HONG ; Dea Kyoung KIM ; Mun Young KANG
Journal of the Korean Geriatrics Society 2005;9(2):98-119
BACKGROUND: The purpose of the research was to find significant factors that were related to the therapeutic compliance of hyper- tension(HT). METHODS: Hypertensive 354 patients from 932 rural elderly were measured blood pressure and administered the questionnaire during August 2003. Operational definition of therapeutic compliance was the state of care and management of HT. The data were analysed by univariate analysis and multivariate regression model. RESULTS: Results of univariate analysis, the seriousness, the barriers, the benefits, and the patients who have family members or friends suffering from HT, the motive of the behavior were significant variables for acceptance rate of the caring HT(p<0.01). Result of multiple logistic regression on participating caring process in HT, significant prediction variable were the subjects who had spouses, long ongoing caring process, no drinking habits, mind set that considers the high blood pressure as a serious disease, families and friends who had complications, didn't feel that taking the medication is not uncomfortable if they haven't experienced the side effect during the caring process. CONCLUSION: According to this result, we should consider major prediction variables to increasing the therapeutic compliance of hypertensive patients and developing the program for controlling hypertensive patients.
Aged*
;
Blood Pressure
;
Compliance*
;
Drinking
;
Friends
;
Humans
;
Hypertension*
;
Logistic Models
;
Surveys and Questionnaires
;
Spouses

Result Analysis
Print
Save
E-mail